IATDMCT Congress 2025 – Singapore, Sep 21 – 24

It is with warm hearts and open arms that we welcome you to the 23rd Congress of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT 2025) to be held from Sunday 21 September to Wednesday 24 September 2025 in Singapore. The congress venue, the Grand Copthorne Waterfront Hotel, is ideally located in the heart of Singapore, within walking distance of a range of fantastic restaurants, tourist attractions and hotels.

IATDMCT 2025 will bring together leading international scientists and healthcare professionals who are actively working in the fields of Therapeutic Drug Monitoring and Clinical Toxicology. The theme of the congress is Creative solutions for global challenges. The congress will consist of world class plenary speakers, innovative symposia and practical workshops across all the major areas of therapeutics and toxicology with a unique Asia Pacific flavour. The congress will provide the opportunity for researchers and clinicians from around the world to come together and share their research and experiences in basic, clinical and translational pharmacology and clinical toxicology.

Singapore is a major international hub with over 100 airlines offering direct flights from all over the world. It hosts world class universities, internationally recognised hospitals and research institutes, as well as being an ideal venue with a warm climate and a fantastic base for exploring some of the great attractions that Asia has to offer. Several top tourist attractions are accessible by public transport including the excitement of Sentosa Island, the enchanting Gardens by the Bay, the famous shopping on Orchard Road, experience a Singapore Sling at the Raffles Hotel or visit one of the many Hawker Centres to taste the incredible local cuisine.

Plan your presentation and please join us to expand your knowledge and network within the Asia Pacific region and make new friends.

IMPORTANT DATES

2024

• 13 September: Abstract submission opens – Submit Now!
• November: Registration opens

2025

• 28 February: Abstract submission deadline – Submit Now!
• 14 April: Abstract notification
• 20 June: Early registration deadline
• 18 July: Accommodation booking deadline
• 21 September: Congress commences

Congress Co-Chairs:
Sophie Stocker and Jana Stojanova

Congress website: iatdmct2025.org/

Contact Us: iatdmct2025@expertevents.com.au

See you in Singapore in 2025!

In this issue:

• Official Launch of the IATDMCT Mentor-Mentee Program
• Meet the IATDMCT Young Scientist Committee!
• Saliva: A potential alternative matrix for mycophenolate TDM in paediatric patients
• Dried blood sampling: challenges and opportunities

Available in your choice of format:                  

Note: You must be logged in to access these download links.

Find the latest news and follow our IATDMCT institutional page on LinkedIn, X(Twitter) @IATDMCT or Instagram!

Stay ahead with the latest scientific research developments in the fields of TDM and CT!

The monthly Therapeutic Drug Monitoring column provides you with the latest posts of ahead-of-print. Bringing to you articles posted online October 10 – November 7, 2024:

ORIGINAL ARTICLES:

• Precision Dosing of Intravenous Tocilizumab: Development of Pharmacokinetic Model–Derived Tapering Strategies for Patients With Rheumatoid Arthritis
  Hooijberg, Femke; van den Berg, Stefan P. H.; Layegh, Zohra; Leeuw, Maureen; Elkayam, Ori; de Vries, Annick; Nurmohamed, Mike; Rispens, Theo; Dorlo, Thomas P. C.; Wolbink, Gertjan
  November 7, 2024
• Examining Whole Blood, Total and Free Plasma Tacrolimus in Elderly Kidney Transplant Recipients
  Cossart, Amelia R.; Isbel, Nicole M.; Campbell, Scott B.; McWhinney, Brett; Staatz, Christine E.
  November 7, 2024
• Untangling the Exposure–Response Relationship of Allopurinol in the Setting of Chronic Kidney Disease and Diuretic Use: Implications for Dosing
  Hishe, Hailemichael Z.; Stocker, Sophie L.; Stamp, Lisa K.; Dalbeth, Nicola; Merriman, Tony R.; Wright, Daniel F.B.
  November 6, 2024
• Evaluation of Effective Half-Life and Its Impact on Time to Steady State for Oral MeltDose Tacrolimus (LCPT) in De Novo Kidney Transplant Recipients
  Momper, Jeremiah D.; Venkataramanan, Raman; Jantz, Arin S.; Cibrik, Diane M.; Birdwell, Kelly; Nguyen, Tk; Masters, Brian M.; Patel, Samir J.
  October 24, 2024
• Mechanism-Based Pharmacokinetic/Pharmacodynamic Model of Voriconazole for Predicting the Clinical Outcomes of Adult Patients with Invasive Aspergillosis
  Duangpraphat, Monchai; Wilson, Richard C.; Rawson, Timothy M.; Santimaleeworagun, Wichai; Nasomsong, Worapong; Holmes, Alison H.; Vasikasin, Vasin
  October 22, 2024
• Liquid Chromatography–Tandem Mass Spectrometry Method for Therapeutic Drug Monitoring of Dalbavancin in Plasma of Pediatric and Young Adult Patients
  Cafaro, Alessia; Mariani, Marcello; Pigliasco, Federica; Baiardi, Giammarco; Barco, Sebastiano; Biondi, Margherita; Mesini, Alessio; Russo, Chiara; Saffioti, Carolina; Mattioli, Francesca; Castagnola, Elio; Cangemi, Giuliana
  October 10, 2024

REVIEW ARTICLES:

• miRNAs, dd-cf-DNA, and Chemokines as Potential Noninvasive Biomarkers for the Assessment of Clinical Graft Evolution and Personalized Immunosuppression Requirement in Solid Organ Transplantation
  Millán, Olga; Julian, Judit; Brunet, Mercè
  November 5, 2024
• A Narrative Review of Chromatographic Bioanalytical Methods for Quantifying Everolimus in Therapeutic Drug Monitoring Applications
  Nascimento, Julia O.; Costa, Edlaine R.; Estrela, Rita; Moreira, Fernanda L.
  October 24, 2024

LETTER TO THE EDITOR:

• Maternal Serum and Cord Blood Levels of Levetiracetam and Valproate at Delivery and Their Associations With Neonatal Abstinence–Related Symptoms
  Ozawa, Shusuke; Matsuzawa, Natsuko; Fuseya, Chiho; Kikuchi, Norihiko; Shiozawa, Tanri; Naito, Takafumi
  October 15, 2024

EDITORIAL:

• Therapeutic Drug Monitoring of Psychotropic Drugs: What We Know, What We Don't, and the Controversies
  Spigset, Olav

››Submit your high quality research – Information for authors.

Pharmacogenetics is increasingly used and serves as a powerful tool to improve treatment outcomes. By analyzing genetic polymorphisms in drug metabolism enzymes and transporters, we can better inform drug selection and dosage adjustments. Pharmacogenetics complements therapeutic drug monitoring, enabling comprehensive treatment optimization. When treatments fail or adverse drug reactions occur, pharmacogenetics can often provide explanations. We are now at a pivotal moment for implementing this strategy on a large scale.

In this episode, the Chair and Vice-Chair of the IATDMCT pharmacogenetic scientific committee will provide a comprehensive overview of pharmacogenetics fundamentals.

Listen Now!

Are you aware of additional events of potential interest for the IATDMCT society? Share this information with your IATDMCT colleagues by posting it on our Events Calendar.

» Click here to Post an Event on our Online Events Calendar today!

Visit the IATDMCT Events Calendar and stay informed about the upcoming TDM and CT Meetings. By doing this you can comfortably and directly reach all related online resources.

IATDMCT Webinar: Optimizing Prescription in LMIC based on Therapeutic Drug Monitoring and PKPD
December 3, 2024, 11:30 AM – 12:30 PM GMT

PROGRAM INCLUDES:

• TDM of Vancomycin in Resource-Limited Regions
  Dr. Ronaldo Morales, PharmD, Division of Clinical Pharmacology, Cincinnati Children's Hospital, USA
• Meropenem: A PK/PD-Based Approach
  Prof. Hoa Vu, National DI&ADR Center of Vietnam
• What is the cost of TDM?
  Prof. Jane Carland, Department of Clinical Pharmacology & Toxicology, Therapeutics Centre, St. Vincent’s Hospital Sydney, Australia
• Barriers and Solutions: TDM in LMICs
  Prof. Catriona Waitt, Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda

Register Now!

PROGRAM INCLUDES:

• Guest Lecture: Affordability and accessibility of TDM in India
  Dr. Smita Pattanaik, Professor, Clinical Pharmacology Unit, Post Graduate Institute of Medical Education and Research, Chandigarh, India
• Presentation: Levetiracetam and high dose methotrexate – Assessing the potential risk of drug-drug interaction
  Dr. Vandana G, Assistant professor, Dept of Clinical Pharmacology & Therapeutics, NIMS Hyderabad, India
• Presentation: Role of pharmacologist in interpreting TDM results for personalized medicine
  Dr. P Sravana Sandhya, Assistant professor, Dept of Clinical Pharmacology & Therapeutics, NIMS Hyderabad

Register Now!

IATDMCT meet the expert workshop

5 December 2024, Amsterdam, NL
1:30pm-4:00pm

A collaborative effort between IATDMCT committees:
Europe Regional Section Committee
Clinical Toxicology & Drugs of Misuse Committee
TDM of Biologics Committee

Register now by emailing Stefan van den Berg at s.vandenberg@sanquin.nl

Register now

Co-editor: Manuela Neuman
Co-editor: Ryuji Kato
Co-editor: Miao Yan

NOTE: Items appearing in the IATDMCT monthly E-News do not necessarily have the endorsement of the Association.